TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

000766

CNE000000735

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
16.42 ^CNY	-4.53%		-12.94%	-17.65%

04-22	Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(XSEC:000766) dropped from S&P Global BMI Index

December 21, 2020 at 12:00 am

Latest news about Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(XSEC:000766) added to S&P Global BMI Index	23-09-18	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-20	CI
Chen Xinkai, Yu Fengchang, Han Lili, and Wei Wei completed the acquisition of a 7.24% stake in Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd from Beijing Jinshang Lianmeng Investment Management Co., Ltd.	23-08-03	CI
Chen Xinkai, Yu Fengchang, Han Lili, and Wei Wei agreed to acquire a 7.24% stake in Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd from Beijing Jinshang Lianmeng Investment Management Co., Ltd.	23-08-02	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Approves Board Elections	23-07-13	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-18	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-19	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(XSEC:000766) dropped from S&P Global BMI Index	20-12-21	CI
Tonghua Golden-Horse Pharmaceutical Industry Co, cancelled the acquisition of Jixi Jikuang Hospital Co., Ltd. and Shuangyashan Shuangkuang Hospital Co., Ltd. from Suzhou Industrial Park Dexin Yili Investment Center (Limited Partnership) and others.	20-11-06	CI
Tibet Dechangtai Pharmaceutical Technology Co., Ltd. signed a share transfer agreement to acquire Lhasa Yongkang Medicine Co., Ltd. from Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd for CNY 5.1 million.	20-11-05	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-19	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-28	CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-28	CI

Chart Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Duration

Period

Chart Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

More charts

TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main products consist of Chinese patent drugs, chemical drugs and bulk drugs, among others. The Companyâs products are used in anti-tumor, microbial, digestive system, skeletal and muscle system, gynecology, nervous system and other areas. The Company distributes its products mainly in domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-19 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD	-17.65%	2.2B
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals